📢 New preprint alert! 📄 A major update from the #DocTISProject is now on bioRxiv. 🔬 Led by CNAG with key partners, the study maps immune cell activity to advance our understanding of #inflammation & improve #patientcare. 👉 doctis.eu/doctis-study-i… #biorxiv

🚀 #DocTISProject at #Immunology2025, the annual meeting of The American Association of Immunologists (AAI)! 🚨 Don’t miss Antonio Julià's presentation on Monday, 5 May at 16:15 in Room 312 of HawaiiConventionCtr! 🚨 👉 Learn more: doctis.eu/doctis-researc… #Immunology #AAI2025 #IMID #IMIDs #AutoimmuneTherapies

🇪🇺 Celebrating #EuropeDay! 🤝 Today marks the 75th anniversary of the Schuman Declaration, a step towards a united Europe. 🧬 In that same spirit, #DocTISProject unites research centres from 5 countries to improve treatments for 6 #IMDS. 🔗 Learn more: doctis.eu

🚀 Research from #DocTISProject presented at The American Association of Immunologists (AAI) annual meeting! 🔬 Dr Antonio Julià (Vall d'Hebron Institut de Recerca) attended #Immunology2025 to introduce key advances in identifying effective #drugcombinations for #IMIDs. 👉 More details: doctis.eu/combination-th… #Immunology #AAI2025 #IMID

💜Today is #WorldIBDDay2025! 📢 Let’s break the silence around #inflammatoryboweldiseases (IBDs) like Crohn’s & ulcerative colitis, 2 of the 6 conditions studied by #DocTISProject. 🔗 Learn more: doctis.eu/project/ 🔗 Activities: efcca.org/activities/wor… #IBDHasNoBorders

🎤 “I was hoping for a positive pregnancy test and instead received a chronic illness diagnosis. I felt awful” ❤️ Meet Sandra Xiques, member of the #DocTISProject family, living with #RheumatoidArthritis. 🔗 Full interview: doctis.eu/interview-sand… #PatientVoices #IMID #IMIDs

✨ #DocTISProject at Soc.Esp.Reumatología's #SER2025 Congress. 📍 Vall d'Hebron Institut de Recerca presented 2 studies using multi-omics & systems biology to personalize treatments for #IMIDs, drawing strong interest and reinforcing DocTIS’ role in precision #rheumatology. 🔗 More: doctis.eu/doctis-congres…

🚨 Join us at #EULAR2025 in #Barcelona! 📣 The #DocTISProject will take the stage at this prestigious #Rheumatology event hosted by EULAR. 🗓️ Fri, June 13 📍 Fira Barcelona 🎙️ Antonio Julià from Vall d'Hebron Institut de Recerca will present our latest study. 🔗 More: doctis.eu/doctis-study-e… #IMID

🚨 #DocTISProject awarded at #EULAR2025! 🎉 Dr. Antonio Julià, from Vall d'Hebron Institut de Recerca, received the “EULAR 2025 Abstract Award” at the #Rheumatology congress in Barcelona, hosted by EULAR. 📣 Don't miss Toni presenting our award-winning study: doctis.eu/eular-congress… #IMIDResearch

🔬 Strong scientific interest in the #DocTISProject study at #EULAR2025! 🎙️ Antonio Julià from Vall d'Hebron Institut de Recerca presented a study to an engaged audience of around 80 attendees at the leading #Rheumatology event hosted by EULAR. 👉 Discover more here: doctis.eu/scientific-int… #EULAR

📣 Kicking off our #DocTISProject PI interview series with Britta Siegmund, from Charité - Universitätsmedizin Berlin: “Our disease-specific analyses have gone beyond the theoretical; they’ve led to real action”. 👉 Read more: doctis.eu/britta-siegmun… #IMID #IMIDs #Rheumatology #Gastroenterology

📣 In our latest PI interview, we speak with Giampiero Girolomoni, Head of the #Dermatology Section at Università di Verona: 🗨️ “I was captivated by the ambitious goals of the #DocTISProject”. 👉 Read more: doctis.eu/giampiero-giro… #IMID #IMIDs #AutoimmuneTherapies #IMIDResearch

🔬 Meet the minds behind the #DocTISProject! 🎤 We spoke with Ernest Choy, Prof. & Head of #Rheumatology at Cardiff University: 📣 “I expect more patients will achieve remission with combination biologic treatment”. 👉 doctis.eu/ernest-choy-pa… #IMID #IMIDs #IMIDResearch #Autoimmune

🔬 Our #DocTISProject interview series continues! 🎤 Meet IMIDomics COO #ManuelLopezFigueroa: “DocTIS can reduce time to effective treatment, minimize side effects & improve long-term disease management”. 👉 Read more: doctis.eu/manuel-lopez-f… #IMID #IMIDs #IMIDResearch

📢 A #DocTISProject study will be presented at #Viszeralmedizin2025! 🎤 Prof. Britta Siegmund (Charité - Universitätsmedizin Berlin) will share new findings at leading #Gastroenterology event. 📍 Sept 19 🌆 Leipzig, Germany 🔗 doctis.eu/doctis-congres… #IMID #IMIDs #IMIDResearch #MedicalResearch

📢 Don’t miss Prof. Britta Siegmund from Charité - Universitätsmedizin Berlin at #Viszeralmedizin2025! 🎤 She will present latest findings from the #DocTISProject. 📅 Sept 19 🕒 15:05 CEST 📍 Leipzig, Germany (@CongressCenterL) 🔗 doctis.eu/doctis-congres… #Gastroenterology #MedicalResearch

📢#DocTISProject findings will be showcased at #UEGWeek2025, Europe’s leading #Gastroenterology congress by @my_UEG. 🔬 On Oct 6, Prof. Britta Siegmund (Charité - Universitätsmedizin Berlin) presents the first large-scale scRNA-seq analysis of drug responses in #IMIDs. 👉 doctis.eu/doctis-ueg-week

🔬 Our #DocTISProject interview series continues! 🎤 Today: Richard M. Myers, CSO of HudsonAlpha. 📣 “I have high hopes for the combination therapy being successful”. 👉 Learn how #Genomics is advancing personalized #IMID treatment: doctis.eu/richard-myers-… #IMIDs #IMIDResearch